1. Consensus report of the International Society of Gastrointestinal Oncology on Therapeutic Progress in Advanced Pancreatic Cancer;Hochster;Cancer,2006
2. Gemcitabine versus cisplatin, epirubicin, 5-fluorouracil, gemcitabine in advanced pancreatic cancer: a phase III trial;Reni;Lancet Oncol.,2005
3. Final results of a randomized phase III trial of Gemcitabine (G) versus PEFG regimen (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in locally advanced or metastatic pancreatic adenocarcinoma (PA);Reni;J. Clin. Oncol.,2004
4. Gemcitabine versus FLEC regimen given intra-arterially to patients with unresectable pancreatic cancer: a prospective randomized phase III trial of the Italian society for integrated locoregional therapy in oncology;Cantore;J. Chemother.,2004
5. Erlotinib improves survival when added to gemcitabine in patients with advanced pancreatic cancer. A phase III trial of the National Cancer Institute of Canada Clinical Trial Group (NCIC-CTG);Moore;J. Clin. Oncol.,2005